Showing 16,281 - 16,300 results of 42,751 for search '(( 5 ((mean decrease) OR (point decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 1.38s Refine Results
  1. 16281
  2. 16282
  3. 16283
  4. 16284

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  5. 16285

    Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  6. 16286

    Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  7. 16287

    Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  8. 16288

    Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  9. 16289

    A binding mode landscape for disordered protein interactions. by Attila Horvath (285787)

    Published 2020
    “…Context-dependent <b>disorder-to-order</b> binding is exemplified by the <b>polymorphic interactions</b> of the ribosomal S6 kinase 1 (RSK1, residues 697–703, <i>light blue dots</i>), which adopts different secondary structures upon binding to S100B, corresponding to autoinhibited and active forms (PDB:5csf, 5csi, 5csj [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007864#pcbi.1007864.ref023" target="_blank">23</a>]). …”
  10. 16290

    Effect of MMP9 on phFAK and ILK expression. by Nabila Djaziri (17537499)

    Published 2023
    “…<p>(A, B) Comparative phFAK expression in jck-MMP9+/+ and jck-MMP9-/- kidneys. …”
  11. 16291
  12. 16292
  13. 16293

    A story about oxygen nanobubbles (RNS60) by Jorge H Ramirez (587826)

    Published 2014
    “…In addition, Revalesio states that RNS60 decrease muscle fatigue and improve exercise performance.[6]</p> <p>Reliant Water is a sport beverage produced by Revalesio and available to the public at the price of $100 USD per 32 bottles. …”
  14. 16294
  15. 16295

    Examination of mitochondrial function and cell viability in <i>PLA2G6</i>-KD cells. by Goichi Beck (818821)

    Published 2015
    “…(B) Expression levels of CCO are decreased in <i>PLA2G6</i>-KD cells compared with those of SH-SY5Y cells treated with negative control siRNA with statistical significance (*<i>p < 0</i>.…”
  16. 16296
  17. 16297
  18. 16298
  19. 16299

    Effects of heterogeneity and noise on homeostatic stability of a network. by Daniel Harnack (501634)

    Published 2015
    “…The curve represents the mean maximal recurrence allowed to ensure a stable system. It decreases with heterogeneity. …”
  20. 16300

    Behavior of a dynamic cytoskeleton under shear flow. by Thomas G. Fai (4500571)

    Published 2017
    “…<p>(a) <i>I</i><sub>2</sub>/<i>I</i><sub>1</sub> over time for <i>k</i><sub>off</sub> = 0, 10, and 100 s<sup>−1</sup>, (b) The lower effective shear modulus for a dynamic network leads to a higher dimensionless capillary number and greater deformations, as evidenced by the greater maximum value of <i>I</i><sub>1</sub> for the network with the fastest rate of remodeling, (c) The total number of irreversibly broken edges is plotted versus time. …”